{"id":"W2941374949","doi":"10.1097/01.ju.0000557495.41260.09","title":"LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Mirabegron; Medicine; Tamsulosin; Overactive bladder; Urology; Hyperplasia; Placebo; Benign prostatic hyperplasia (BPH); Internal medicine; Prostate; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001187398,0.0002737081,0.00155155,0.0003864541,0.000328069,0.0009968152,0.0004639293,0.001013282,0.01161078],"category_scores_gemma":[0.001464038,0.0002366366,0.001563649,0.0002902677,0.0003223449,0.0005653401,0.000343796,0.001493938,0.001492468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000401035,"about_ca_system_score_gemma":0.0006777772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007231223,"about_ca_topic_score_gemma":0.001786286,"domain_scores_codex":[0.9995621,0.0002010531,0.00004118343,0.0000380753,0.0001010027,0.00005655151],"domain_scores_gemma":[0.9989035,0.0002640962,0.000257688,0.00005349519,0.0001375513,0.0003836974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6857104,0.01396366,0.005225116,0.001975597,0.001532315,0.000195072,0.0001462323,0.0003918453,0.01288971,0.0004807707,0.0134716,0.2640176],"study_design_scores_gemma":[0.2957882,0.5979758,0.06225309,0.001000966,0.00248054,0.000738525,0.0003380817,0.001702715,0.006907982,0.0005512665,0.0301593,0.0001034868],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9414213,0.03409347,0.0003400648,0.002760725,0.001315093,0.001100129,0.002802242,0.0002965169,0.0158705],"genre_scores_gemma":[0.9761583,0.008601665,0.0007900997,0.002657433,0.0010064,0.0005546843,0.001859362,0.00003849183,0.008333661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01161078,"threshold_uncertainty_score":0.0388419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02640289525704178,"score_gpt":0.3162269769792337,"score_spread":0.289824081722192,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}